Exchange protein directly activated by cAMP plays a critical role in regulation of vascular fibrinolysis

Xi He, Aleksandra Drelich, Shangyi Yu, Qing Chang, Dejun Gong, Yixuan Zhou, Yue Qu, Yang Yuan, Zhengchen Su, Yuan Qiu, Shao-Jun Tang, Angelo Gaitas, Thomas Ksiazek, Zhiyun Xu, Jia Zhou, Zongdi Feng, Maki Wakamiya, Fanglin Lu, Bin Gong

Research output: Contribution to journalArticle

Abstract

Plasmin-mediated fibrinolysis at the surface of vascular endothelial cells (SVEC) plays a key role in maintaining vascular hemostasis, in which the cAMP pathway participates. After externalization to the SVEC, annexin A2 (ANXA2) serves as a platform for conversion of plasminogen to plasmin. Here we describe a regulatory role of the exchange protein directly activated by cAMP (EPAC) in ANXA2 externalization and vascular fibrinolysis. Knockout of EPAC1 in mice results in a decreased ANXA2 expression on the SVEC associated with increased fibrin deposition and fibrinolytic dysfunction. Reduced levels of EPAC1 are also found in endocardial tissues beneath atrial mural thrombi in patients. Notably, administration of recombinant ANXA2 ameliorates fibrinolytic dysfunction in the EPAC1-null mice. Mechanistically, EPAC1 regulates the SVEC plasminogen conversion depended on ANXA2. EPAC1 promotes tyrosine-23 phosphorylation of ANXA2, a prerequisite for its recruitment to the SVEC. Our data thus reveal a novel regulatory role for EPAC1 in vascular fibrinolysis.

Original languageEnglish (US)
Pages (from-to)1-12
Number of pages12
JournalLife Sciences
Volume221
DOIs
StatePublished - Mar 15 2019

Fingerprint

Annexin A2
Endothelial cells
Fibrinolysis
Blood Vessels
Endothelial Cells
Plasminogen
Fibrinolysin
Proteins
Annexins
Phosphorylation
Hemostasis
Fibrin
Tyrosine
Thrombosis
Tissue

Keywords

  • Annexin A2
  • Atomic force microscopy
  • EPAC1
  • Thrombosis
  • Vascular endothelial fibrinolysis

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Exchange protein directly activated by cAMP plays a critical role in regulation of vascular fibrinolysis. / He, Xi; Drelich, Aleksandra; Yu, Shangyi; Chang, Qing; Gong, Dejun; Zhou, Yixuan; Qu, Yue; Yuan, Yang; Su, Zhengchen; Qiu, Yuan; Tang, Shao-Jun; Gaitas, Angelo; Ksiazek, Thomas; Xu, Zhiyun; Zhou, Jia; Feng, Zongdi; Wakamiya, Maki; Lu, Fanglin; Gong, Bin.

In: Life Sciences, Vol. 221, 15.03.2019, p. 1-12.

Research output: Contribution to journalArticle

He, X, Drelich, A, Yu, S, Chang, Q, Gong, D, Zhou, Y, Qu, Y, Yuan, Y, Su, Z, Qiu, Y, Tang, S-J, Gaitas, A, Ksiazek, T, Xu, Z, Zhou, J, Feng, Z, Wakamiya, M, Lu, F & Gong, B 2019, 'Exchange protein directly activated by cAMP plays a critical role in regulation of vascular fibrinolysis', Life Sciences, vol. 221, pp. 1-12. https://doi.org/10.1016/j.lfs.2019.02.014
He, Xi ; Drelich, Aleksandra ; Yu, Shangyi ; Chang, Qing ; Gong, Dejun ; Zhou, Yixuan ; Qu, Yue ; Yuan, Yang ; Su, Zhengchen ; Qiu, Yuan ; Tang, Shao-Jun ; Gaitas, Angelo ; Ksiazek, Thomas ; Xu, Zhiyun ; Zhou, Jia ; Feng, Zongdi ; Wakamiya, Maki ; Lu, Fanglin ; Gong, Bin. / Exchange protein directly activated by cAMP plays a critical role in regulation of vascular fibrinolysis. In: Life Sciences. 2019 ; Vol. 221. pp. 1-12.
@article{1d71f62cf4d9450a9d0880b6604a9a22,
title = "Exchange protein directly activated by cAMP plays a critical role in regulation of vascular fibrinolysis",
abstract = "Plasmin-mediated fibrinolysis at the surface of vascular endothelial cells (SVEC) plays a key role in maintaining vascular hemostasis, in which the cAMP pathway participates. After externalization to the SVEC, annexin A2 (ANXA2) serves as a platform for conversion of plasminogen to plasmin. Here we describe a regulatory role of the exchange protein directly activated by cAMP (EPAC) in ANXA2 externalization and vascular fibrinolysis. Knockout of EPAC1 in mice results in a decreased ANXA2 expression on the SVEC associated with increased fibrin deposition and fibrinolytic dysfunction. Reduced levels of EPAC1 are also found in endocardial tissues beneath atrial mural thrombi in patients. Notably, administration of recombinant ANXA2 ameliorates fibrinolytic dysfunction in the EPAC1-null mice. Mechanistically, EPAC1 regulates the SVEC plasminogen conversion depended on ANXA2. EPAC1 promotes tyrosine-23 phosphorylation of ANXA2, a prerequisite for its recruitment to the SVEC. Our data thus reveal a novel regulatory role for EPAC1 in vascular fibrinolysis.",
keywords = "Annexin A2, Atomic force microscopy, EPAC1, Thrombosis, Vascular endothelial fibrinolysis",
author = "Xi He and Aleksandra Drelich and Shangyi Yu and Qing Chang and Dejun Gong and Yixuan Zhou and Yue Qu and Yang Yuan and Zhengchen Su and Yuan Qiu and Shao-Jun Tang and Angelo Gaitas and Thomas Ksiazek and Zhiyun Xu and Jia Zhou and Zongdi Feng and Maki Wakamiya and Fanglin Lu and Bin Gong",
year = "2019",
month = "3",
day = "15",
doi = "10.1016/j.lfs.2019.02.014",
language = "English (US)",
volume = "221",
pages = "1--12",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Exchange protein directly activated by cAMP plays a critical role in regulation of vascular fibrinolysis

AU - He, Xi

AU - Drelich, Aleksandra

AU - Yu, Shangyi

AU - Chang, Qing

AU - Gong, Dejun

AU - Zhou, Yixuan

AU - Qu, Yue

AU - Yuan, Yang

AU - Su, Zhengchen

AU - Qiu, Yuan

AU - Tang, Shao-Jun

AU - Gaitas, Angelo

AU - Ksiazek, Thomas

AU - Xu, Zhiyun

AU - Zhou, Jia

AU - Feng, Zongdi

AU - Wakamiya, Maki

AU - Lu, Fanglin

AU - Gong, Bin

PY - 2019/3/15

Y1 - 2019/3/15

N2 - Plasmin-mediated fibrinolysis at the surface of vascular endothelial cells (SVEC) plays a key role in maintaining vascular hemostasis, in which the cAMP pathway participates. After externalization to the SVEC, annexin A2 (ANXA2) serves as a platform for conversion of plasminogen to plasmin. Here we describe a regulatory role of the exchange protein directly activated by cAMP (EPAC) in ANXA2 externalization and vascular fibrinolysis. Knockout of EPAC1 in mice results in a decreased ANXA2 expression on the SVEC associated with increased fibrin deposition and fibrinolytic dysfunction. Reduced levels of EPAC1 are also found in endocardial tissues beneath atrial mural thrombi in patients. Notably, administration of recombinant ANXA2 ameliorates fibrinolytic dysfunction in the EPAC1-null mice. Mechanistically, EPAC1 regulates the SVEC plasminogen conversion depended on ANXA2. EPAC1 promotes tyrosine-23 phosphorylation of ANXA2, a prerequisite for its recruitment to the SVEC. Our data thus reveal a novel regulatory role for EPAC1 in vascular fibrinolysis.

AB - Plasmin-mediated fibrinolysis at the surface of vascular endothelial cells (SVEC) plays a key role in maintaining vascular hemostasis, in which the cAMP pathway participates. After externalization to the SVEC, annexin A2 (ANXA2) serves as a platform for conversion of plasminogen to plasmin. Here we describe a regulatory role of the exchange protein directly activated by cAMP (EPAC) in ANXA2 externalization and vascular fibrinolysis. Knockout of EPAC1 in mice results in a decreased ANXA2 expression on the SVEC associated with increased fibrin deposition and fibrinolytic dysfunction. Reduced levels of EPAC1 are also found in endocardial tissues beneath atrial mural thrombi in patients. Notably, administration of recombinant ANXA2 ameliorates fibrinolytic dysfunction in the EPAC1-null mice. Mechanistically, EPAC1 regulates the SVEC plasminogen conversion depended on ANXA2. EPAC1 promotes tyrosine-23 phosphorylation of ANXA2, a prerequisite for its recruitment to the SVEC. Our data thus reveal a novel regulatory role for EPAC1 in vascular fibrinolysis.

KW - Annexin A2

KW - Atomic force microscopy

KW - EPAC1

KW - Thrombosis

KW - Vascular endothelial fibrinolysis

UR - http://www.scopus.com/inward/record.url?scp=85061246932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061246932&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2019.02.014

DO - 10.1016/j.lfs.2019.02.014

M3 - Article

VL - 221

SP - 1

EP - 12

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

ER -